ADVANTAN Presentation Uses - Medsafe

ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.

  Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate

LOXALATE 1. Product Name - Medsafe Home Page

Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.

  Risks, Combination

DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …

New Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …

  Sheet, Data, Data sheet, Clexane

SEPTANEST Articaine hydrochloride 4% with …

SEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.

  Articaine

BOOSTRIX - Medsafe Home Page

1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.

  Information, Boostrix

NEW ZEALAND DATA SHEET - Medsafe

NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a

  Cymevene

Edition Draft - Medsafe

Part 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for

  Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice

Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …

New Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …

  Product, Name, Sheet, Data, Data sheet 1 product name

NEW ZEALAND DATA SHEET MESTINON® - Medsafe

NEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to

  Myasthenia, Gravis, Myasthenia gravis, Mestinon

DATA SHEET PREDNISONE - Medsafe

• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since

  Myasthenia, Gravis, Myasthenia gravis, Prednisone

Azulfidine sulfasalazine tablets, USP DESCRIPTION

Azulfidine ® sulfasalazine tablets, USP DESCRIPTION . AZULFIDINE Tablets contain sulfasalazine, 500 mg, for oral administration. Therapeutic Classification

  Descriptions, Tablets, Sulfasalazine, Azulfidine sulfasalazine tablets, Azulfidine, Usp description, 174 sulfasalazine tablets

SALAZOPYRIN - Medsafe

SALAZOPYRIN® Tablets and EN tablets Sulfasalazine Consumer Medicine Information . What is in this leaflet stiffness in your joints. "Salazopyrin" will be used in this

  Sulfasalazine

Patient Information Leaflet - Medicines

Page 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN-tabs are and what they are used for

  Sulfasalazine

CIGNA 90 NOWSM MAINTENANCE DRUG LIST

CIGNA 90 NOWSM MAINTENANCE DRUG LIST For customers who must fill their maintenance medications in a 90-day supply Your plan includes a new maintenance medication program called …

  Drug, Maintenance, Lists, Cigna, Cigna 90 nowsm maintenance drug list, Nowsm

DRUGS TO AVOID IN G6PD DEFICIENCY - cych.org.tw

DRUGS TO AVOID IN G6PD DEFICIENCY DEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSIS Pharmacological Class Drugs* Pharmacological Class Drugs* • ß-Naphthol

  Drug, Deficiency, Avoid, Drugs to avoid in g6pd deficiency, G6pd

Photosensitizing Medication List - Vitiligo Support

t a n n i n g f a c t b o o k 2 0 0 8 / 2 0 0 9 c h a p t e r t w o 25 looking fit lookingfit.com Note: Items with an asterisk (*) are more likely

  Lists, Medication, Photosensitizing, Photosensitizing medication list

The EULAR points to consider for use of antirheumatic ...

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation Carina Götestam Skorpen,1,2,3 Maria Hoeltzenbein,4 Angela Tincani,5 Rebecca Fischer-Betz,6 Elisabeth Elefant,7 Christina Chambers,8 Josè da Silva,9 Catherine Nelson-Piercy,10 Irene Cetin,11 Nathalie Costedoat-Chalumeau,12,13 Radboud Dolhain,14 Frauke Förger,15 Munther …

  Drug, Before, Pregnancy, Antirheumatic, Of antirheumatic drugs before pregnancy

Sjögren’s Systemic Manifestations in Sjögren’s Patients ...

SSF16150.04S Sjögren’s Syndrome Foundation’s Clinical Practice Guidelines The Sjögren’s Syndrome Foundation (SSF) has developed the first U.S. Rheumatology Clinical

Inflectra® (infliximab-dyyb) Injectable Medication ...

GR-69299 (1-18) Inflectra ® (infliximab-dyyb) Injectable Medication Precertification Request . Page 3 of 4 (All fields must be completed and legible for Precertification Review.)

  Medication, Request, Precertification, Injectable medication precertification request, Injectable, Infliximab, Infliximab dyyb, Dyyb